CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 10,000 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,277 | 11,212 | ||
| 2024-04-01 | Daly James M Director | Option exercise 10b5-1 | +20,000 | $100.45 | $2.0M | 21,198 |
| 2024-04-01 | Daly James M Director | Option exercise 10b5-1 | +1,577 | $105.08 | $166K | 22,775 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −6,809 | $255.64 | $1.7M | 15,966 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −7,401 | $256.50 | $1.9M | 8,565 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −3,604 | $257.30 | $927K | 4,961 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −1,460 | $258.28 | $377K | 3,501 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −200 | $259.11 | $52K | 3,301 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −800 | $262.01 | $210K | 2,501 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −178 | $263.31 | $47K | 2,323 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −351 | $264.89 | $93K | 1,972 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −500 | $265.49 | $133K | 1,472 |
| 2024-04-01 | Daly James M Director | Sale 10b5-1 | −274 | $266.91 | $73K | 1,198 |
| 2024-04-01 | Daly James M Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 0 | ||
| 2024-04-01 | Daly James M Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,577 | 10,912 | ||
| 2024-03-21 | BAKER BROS. ADVISORS LP Director | Purchase · Common Stock Warrant (right to buy) | +86,741 | $260.00 | $22.6M | 212,188 |
| 2024-03-21 | BAKER BROS. ADVISORS LP Director | Purchase · Common Stock Warrant (right to buy) | +970,951 | $260.00 | $252.4M | 2,493,602 |
| 2024-01-23 | Huntsman Carole Chief Commercial Officer | Grant or award | +3,639 | 11,473 |
Page 36 of 82 · 1,629 trades